Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Attitude and Knowledge of Community Pharmacists to Adverse Drug Reaction Reporting

약물유해반응 보고에 대한 개국약국 약사들의 태도 및 지식에 관한 연구

  • Kim, Hyun-Ah (Continuous Education Center for Advanced Pharmacy College of Pharmacy, Seoul National University)
  • 김현아 (서울대학교 약학대학 약학교육연수원)
  • Received : 2009.10.27
  • Accepted : 2009.12.23
  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to evaluate the attitude and knowledge of community pharmacists to spontaneous adverse drug reaction (ADR) reporting. A survey was conducted in 103 community pharmacists in Seoul and Kyung-Gi Province from September to October, 2009. Almost half (53, 51.5%) and three-fourths (79, 76.7%) of respondents knew they could participate in ADR reporting in the Regional Pharmacovigilance Center (RPC) or Korean Food and Drug Administration (KFDA). However, only three of them have reported an ADR to the RPC and none of them have reported to KFDA. A majority of the respondents (96, 93.2%) felt that ADR reporting was a professional obligation for pharmacists. The purpose of an ADR reporting was incorrectly identified by most pharmacists. ADR reporting was encouraged if the reaction was serious and a new product. The most frequently mentioned barriers to reporting were: uncertainty concerning the causal relationship (86.3%) and not knowing how to report an ADR (83.2%). Only 19 (18.4%) respondents had received education on how to report ADR. Education was the most recognized method of improving ADR reporting. This study showed the knowledge of ADR reporting among community pharmacists is inadequate. Education and training should be reinforced in order to improve ADR reporting by community pharmacists.

Keywords

References

  1. World Health Organization. International Drug Monitoring: The role of the Hospital. Geneva, Switzerland: World Health Organization; 1966. Technical Report Series No. 425.
  2. Bennett CL, Nebeker JR, Yarnold PR et al. Evaluation of serious adverse drug reaction. Arch Intern Med 2007; 167: 1041-49. https://doi.org/10.1001/archinte.167.10.1041
  3. Moore TJ, Cohen MR, Furberg CD. Serious adverse events reported to the Food and Drug Administration, 1995-2005. Arch Intern Med 2007; 167: 1752-59. https://doi.org/10.1001/archinte.167.16.1752
  4. Johnson JA, Bootman JL. Drug-related morbidity and mortality: A cost-of-illness model. Arch Intern Med 1995; 155: 1949-56. https://doi.org/10.1001/archinte.1995.00430180043006
  5. 통계청 Website. Available at http://www.nso.go.kr.
  6. 식품의약품안전청 Website. Available at http://www.kfda.go.kr.
  7. 최남경, 박병주. 우리나라 약물유해반응 감시체계. 예방의학회지 2007; 40; 278-284.
  8. Green FG, Mottram DR, Rower PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmcol 2001; 51: 81- 86.
  9. Oshikoya KA, Awobusuyi JO. Perception of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clinical Pharmacology 2009; 9: 14- 21.
  10. Herdeiro MT, Figuerias A, Polonia J, Gestal-Ostero JJ. Physician's attitudes and adverse drug reaction reporting. A case-control study in Portugal. Drug Safety 2005; 28: 825-833. https://doi.org/10.2165/00002018-200528090-00007
  11. Gootheest AC van, Mes K, Jong-van de Berg LTW de. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract 2002; 10: 267-72. https://doi.org/10.1211/096176702776868460
  12. Green CF, Mottram DR, Raval D, Proudlove C, Randall C. Community pharmaicsts' attitude to adverse drug reaction reporting. Int J Pharm Pract 1999; 7: 92-99. https://doi.org/10.1111/j.2042-7174.1999.tb00955.x
  13. American Society of Health-System Pharmacists. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health-Syst Pharm. 1995; 52: 417-419.
  14. The Learning Center. Pharmacists are number one. Continuing pharmacy education; fall 1999. Canada: University of British Columbia.
  15. Gootheest AC van, Puijenbroek EP van, Jong-van de Berg LTW de. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 205-10. https://doi.org/10.1002/pds.702
  16. Scott HD, Thacher-Renshaw A, Rosenbaun SE, Waters WJ Jr, Green M, Andrew LJ, Faich GA. Physician reporting of adverse reactions: results of the Rhode Island adverse drug reaction reporting project. JAMA 1990; 263: 1785-1788. https://doi.org/10.1001/jama.1990.03440130073028
  17. Figuerias A, Herdeiro MT, Polonia J, Gestal-Ostero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296: 1086-1093. https://doi.org/10.1001/jama.296.9.1086
  18. Kelly M, Kaye KI, Davis SR, et al. Factors influencing adverse drug reaction reporting in New South Wlaes teaching hospitals. Drug Saf 2004; 22: 161-168.
  19. Sweis D, Wong ICK. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf 2000; 23: 165-78 https://doi.org/10.2165/00002018-200023020-00006
  20. Kohen LT, Corrigan JM, Donaldson MS eds. Institude of Medicine report: To error is human: building a safer health system. November 1999. National Academy of Sciences. Available at http://www.iom.edu.